Stock & Company Details
EyePoint Pharmaceuticals Inc $EYPT
Price:
N/A
N/A
86M
$33M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.10
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
EYPT technical indicators
Latest EyePoint Pharmaceuticals Inc (EYPT) indicator readings as of 2026-10-29.
EYPT's 14-day RSI is 15.8, in oversold territory. At $0.38 it is trading 96.6% below its 200-day moving average of $11.06, and below its 50-day average of $3.31. Price sits in the middle of its Bollinger Bands ($-0.86 to $4.75). ADX reads 56.9, indicating a trending market.
Overview
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Finance Bot
Ask your questions
Start by typing a question below.
